atrandi-cover-image

Atrandi Biosciences is advancing the frontier of single-cell analysis with its proprietary Semi-Permeable Capsule (SPC) technology. The platform encapsulates hundreds of thousands of cells in permeable microenvironments, enabling complex, multi-step reactions at scale while preserving single-cell resolution. By combining throughput with precision, Atrandi unlocks true multiomic insights and accelerates biological discovery. Founded in 2016, Atrandi - meaning “you discover” in Lithuanian -embodies the company’s mission to empower scientists to reveal the complexity of life.

Nulla adipisicing do ut aliquip elit tempor fugiat. Mollit est exercitation excepteur ea consequat ullamco Lorem ex id. Ipsum nostrud Lorem dolor nisi do est in ex amet eu nostrud. Amet commodo consectetur enim nostrud dolore sint excepteur irure aliqua consectetur. Veniam occaecat et enim eiusmod qui fugiat eiusmod eiusmod laborum exercitation veniam ipsum velit. Ut veniam cupidatat ea tempor ad ad exercitation amet qui. Esse commodo sint deserunt ut elit minim sint. Amet laborum ut adipisicing minim sunt cillum anim in est ipsum aliquip anim in tempor pariatur.

industries
Milestones

Lux investment: 2025

Founders

Linas Mazutis

Juozas Nainys

Karolis Leonavicius

Dalius Kuciauskas

Rapolas Zilionis

Lux partners
David Yang
Shaq Vayda

Atrandi

Michelle Fang
Prableen Kaur
Bibi Masara
Morgan Roundtree
Ale Salardi
Kyrstin Swan
Emily Haight
Laurence Pevsner
Nat Turner
David Yang
Kim Tran
Tess van Stekelenburg
Andrew Wilson
Tracie Rotter
Stevie Lee
Steven Brody
Shaq Vayda
Shahin Farshchi, PhD
Segolene Scarborough
Sean Traynor
Scott Rubin
Saunaz Moradi
Samuel Arbesman, PhD
Samantha Cho
Peter Hébert
Lindsay Morris
Lan Jiang
Josh Wolfe
Grace Isford
Deena Shakir
Debbie Elsen
Danny Crichton
Cristina Morris
Brandon Reeves
Brad Gritsch
Adam Kalish